Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
By limiting prolonged inflammation, it may reduce secondary tissue damage and support a controlled healing environment
For anyone who's been watching BPC-157 from the sidelines due to regulatory uncertainty, the current environment is significantly clearer than it was 1218 months ago
The phosphorylation of Src and Cav-1 is an important process that mediates the endocytosis of VEGFR2 and triggers the eNOS activation in vascular endothelial cells 19,20
